FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors
MAHLIFE Price Target Potential
| Brokerage | Target | Potential |
|---|---|---|
| Sharekhan | 340 | -38.37% |
| ICICIdirect.com | 380 | -23.80% |
| HDFC Securities | 349 | -34.80% |
MAHLIFE Ratings
Long term MAHLIFE rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
NaN/5 ( Ratings)
MAHLIFE share price target reports by brokerages below. See what is analyst's view on MAHLIFE share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
- Home
- MAHLIFE Forum
- MAHLIFE Price Target
MAHLIFE Share Price Target
MAHLIFE Share Price Target - Broker Reports - 2022
Sharekhan
Price @ Call: 291
2-Mar-22
Target: 340
BUY
ICICIdirect.com
Price @ Call: 311
13-Feb-22
Target: 380
BUY
HDFC Securities
Price @ Call: 264
8-Feb-22
Target: 349
BUY
ICICIdirect.com
Price @ Call: 264
7-Feb-22
Target: 335
BUY
MAHLIFE Share Price Target - Broker Reports - 2021
ICICIdirect.com
Price @ Call: 278
28-Oct-21
Target: 335
BUY
Sharekhan
Price @ Call: 278
15-Sep-21
Target: 340
BUY
ICICIdirect.com
Price @ Call: 281
14-Sep-21
Target: 325
BUY
ICICIdirect.com
Price @ Call: 762.45
30-Jul-21
Target: 940
BUY
Sharekhan
Price @ Call: 549.1
12-Mar-21
Target: 655
BUY
MAHLIFE Share Price Target - Broker Reports - 2019
ICICIdirect.com
Price @ Call: 374.85
30-Jul-19
Target: 380
HOLD
We like MLD given its strong parentage, the management’s focus onimproving return ratios through strategic partnerships with IFC, HDFC Capital and a comfortable balance sheet. The Rs 1,000 crore worth ongoing projects, in addition to the Rs 1,400-1,500 crore could create enough headroom for the company to drive sales momentum ahead. Nonetheless, we would like to see meaningful improvement in the industrial cluster business before the sunset clause kicks in. Hence, we maintain our HOLD recommendation with a target price of Rs 380/share.
ICICIdirect.com
Price @ Call: 381.33
25-Apr-19
Target: 410
HOLD
We like MLD given its strong parentage, management’s focus on improving return ratios through strategic partnerships with IFC, HDFC Capital and a comfortable balance sheet. Besides this, the company is also looking to expand its residential project portfolio. While the management commentary is encouraging on ramping up its residential portfolio, we would like to see more improvement in the industrial cluster business. Hence, we maintain our HOLD recommendation with a target price of Rs 410/share.
ICICIdirect.com
Price @ Call: 386.67
31-Jan-19
Target: 430
HOLD
MAHLIFE Share Price Target - Broker Reports - 2018
ICICIdirect.com
Price @ Call: 405
29-Oct-18
Target: 450
HOLD
HDFC Securities
Price @ Call: 470.44
17-Sep-18
Target: 565
BUY
ICICIdirect.com
Price @ Call: 535.9
2-Aug-18
Target: 600
BUY
ICICIdirect.com
Price @ Call: 461.5
30-Apr-18
Target: 525
BUY
ICICIdirect.com
Price @ Call: 500.47
1-Feb-18
Target: 570
HOLD
HDFC Securities
Price @ Call: 490.9
15-Jan-18
Target: 635
BUY
MAHLIFE Share Price Target - Broker Reports - 2017
Axis Direct
Price @ Call: 444.65
7-Nov-17
Target: 489
BUY
ICICIdirect.com
Price @ Call: 524.85
20-Sep-17
Target: 605
BUY
Axis Direct
Price @ Call: 412.9
24-Aug-17
Target: 508
BUY
ICICIdirect.com
Price @ Call: 427
2-Aug-17
Target: 520
BUY
MAHLIFE Share Price Target - Broker Reports - 2016
Angel Broking
Price @ Call: 437.5
23-Aug-16
Target: 522
BUY
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.